These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9602211)

  • 21. Psychotic side effects of psychostimulants: a 5-year review.
    Cherland E; Fitzpatrick R
    Can J Psychiatry; 1999 Oct; 44(8):811-3. PubMed ID: 10566114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
    Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
    J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on growth in pemoline-treated children with attention deficit disorder.
    Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A
    Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pemoline-associated hepatic injury.
    Nehra A; Mullick F; Ishak KG; Zimmerman HJ
    Gastroenterology; 1990 Nov; 99(5):1517-9. PubMed ID: 2210262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study.
    Heiligenstein E; Johnston HF; Nielsen JK
    J Am Coll Health; 1996 Jul; 45(1):35-9. PubMed ID: 8708264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coming into focus. Pharmacologic treatment for ADHD.
    McDonnell MA; Moffett C
    Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure to monitor.
    Avery JK
    Tenn Med; 1997 Aug; 90(8):311-2. PubMed ID: 9260505
    [No Abstract]   [Full Text] [Related]  

  • 31. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity.
    Collier CP; Soldin SJ; Swanson JM; MacLeod SM; Weinberg F; Rochefort JG
    Clin Pharmacokinet; 1985; 10(3):269-78. PubMed ID: 4017397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemoline-induced autoimmune hepatitis.
    Sterling MJ; Kane M; Grace ND
    Am J Gastroenterol; 1996 Oct; 91(10):2233-4. PubMed ID: 8855756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood levels and tolerance to stimulants in ADDH children.
    Swanson JM; Lerner M; Cantwell D
    Clin Neuropharmacol; 1986; 9 Suppl 4():523-5. PubMed ID: 3567959
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
    Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
    J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
    Pelham WE; Swanson JM; Furman MB; Schwindt H
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pemoline-induced Tourette's disorder: a case report.
    Bachman DS
    Am J Psychiatry; 1981 Aug; 138(8):1116-7. PubMed ID: 6942661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemoline-induced abnormal involuntary movements.
    Sallee FR; Stiller RL; Perel JM; Everett G
    J Clin Psychopharmacol; 1989 Apr; 9(2):125-9. PubMed ID: 2723130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance with FDA recommendations for pemoline.
    Sarkis EH
    J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623
    [No Abstract]   [Full Text] [Related]  

  • 39. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
    Riggs PD; Thompson LL; Mikulich SK; Whitmore EA; Crowley TJ
    J Am Acad Child Adolesc Psychiatry; 1996 Aug; 35(8):1018-24. PubMed ID: 8755798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline.
    Sangal JM; Sangal RB; Persky B
    Clin Electroencephalogr; 1995 Oct; 26(4):204-13. PubMed ID: 8575100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.